The global ovarian cancer diagnostics market is projected to grow at a compound annual growth rate (CAGR) of approximately 6% ...
Efficacy and safety of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with solid tumors: Clinical data from advanced cervical cancer and platinum-resistant ...
A study found that the difficulty of surgery and the degree of cancer spread in the abdominal cavity can be predicted only by ...